Cordlife Group Limited (CLIFF)
OTCMKTS · Delayed Price · Currency is USD
0.1721
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Bally's Revenue
In the year 2024, Cordlife Group had annual revenue of 27.65M SGD, down -50.39%. Cordlife Group had revenue of 18.46M in the half year ending December 31, 2024, a decrease of -36.18%.
Revenue
27.65M SGD
Revenue Growth
-50.39%
P/S Ratio
1.96
Revenue / Employee
51.39K SGD
Employees
538
Market Cap
39.63M USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.65M | -28.08M | -50.39% |
Dec 31, 2023 | 55.73M | 574.00K | 1.04% |
Dec 31, 2022 | 55.16M | -1.51M | -2.67% |
Dec 31, 2021 | 56.67M | -2.32M | -3.93% |
Dec 31, 2020 | 58.99M | -2.59M | -4.21% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |